References
Arrythmias. Heart Rhythm Society. 2004. Available
at
http://hrspatients.org/patients/treatments/cardiac_defibrillators/common_questions.asp.
Accessed Febuary 27, 2006.
Aviles RJ, Martin DO, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003 Dec 16;108(24):3006–10.
Brook RD, Brook JR, Rajagopalan S. Air pollution: the "Heart" of the problem. Curr Hypertens Rep. 2003 Feb;5(1):32-9. Review.
Calder PC, Grimble RF. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S14–S19.
Chung MK. Vitamins, supplements, herbal medicines, and arrhythmias. Cardiol Rev. 2004 Mar;12(2):73–84.
Coromilas J. Obesity and atrial fibrillation: Is one epidemic feeding the other? JAMA. 2004 Nov 24;292(20):2519–20.
Cybulski J, Budaj A, et al. A new-onset atrial fibrillation: The
incidence of potassium and magnesium deficiency. The efficacy of
intravenous potassium/magnesium supplementation in cardioversion to
sinus rhythm. Kardiol Pol. 2004 Jun;60(6):578–81.
Das UN, Ramos EJ, et al. Metabolic alterations during inflammation
and its modulation by central actions of omega-3 fatty acids. Curr Opin
Clin Nutr Metab Care. 2003 Jul;6(4):413–9.
De Caterina R, Madonna R. [Antiarrhythmia effects of omega-3 fatty acids. A review]. Ital Heart J Suppl. 2002 Mar;3(3):297–308.
Durlach J, Bac P, et al. Magnesium status and ageing: An update. Magnes Res. 1998 Mar;11(1):25–42.
Kalus JS, White CM, et al. Indicators of atrial fibrillation risk in
cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg.
2004 Apr;77(4):1288–92.
Kang JX, Leaf A. Prevention of fatal cardiac arrhythmias by
polyunsaturated fatty acids. Am J Clin Nutr. 2000 Jan;71(1
Suppl):202S–7S.
Kaufman JD, Silverstein MA, et al. Atrial fibrillation and sudden
death related to occupational solvent exposure. Am J Ind Med. 1994
May;25(5):731-5.
Khan IA, Nair CK, et al. Acute ventricular rate control in atrial
fibrillation and atrial flutter. Int J Cardiol. 2004 Oct;97(1):7–13.
Korantzopoulos P, Kolettis TM, et al. Oral vitamin C administration
reduces early recurrence rates after electrical cardioversion of
persistent atrial fibrillation and attenuates associated inflammation.
Int J Cardiol. 2005 Jul 10;102(2):321-6.
Lee KW, Lip GY. The role of omega-3 fatty acids in the secondary
prevention of cardiovascular disease. QJM. 2003 Jul;96(7):465–80.
Leonardi M, Bisset J. Prevention of atrial fibrillation. Curr Opin Cardiol. 2005 Sep;20(5):417-23.
Mozaffarian D, Psaty BM, et al. Fish intake and risk of incident atrial fibrillation. Circulation. 2004 Jul 27;110(4):368–73.
Nair SS, Leitch JW, et al. Prevention of cardiac arrhythmia by
dietary (n-3) polyunsaturated fatty acids and their mechanism of
action. J Nutr. 1997 Mar;127(3):383–93.
Pfeiffer H, Al Khaddam M, et al. Sudden death after isobutane
sniffing: a report of two forensic cases. Int J Legal Med. 2005 Dec
21:1-6
Psaty BM, Manolio TA, et al. Incidence of and risk factors for
atrial fibrillation in older adults. Circulation. 1997 Oct
7;96(7):2455–61.
Richter WO. Long-chain omega-3 fatty acids from fish reduce sudden
cardiac death in patients with coronary heart disease. Eur J Med Res.
2003 Aug 20;8(8):332–6.
Routledge HC., Ayres JG. Air pollution and the heart. Occup Med (Lond). 2005 Sep;55(6):439-47.
Slavik RS, Tisdale JE, et al. Pharmacologic conversion of atrial
fibrillation: A systematic review of available evidence. Prog
Cardiovasc Dis. 2001 Sep;44(2):121–52.
Swain R, Kaplan-Machlis B. Magnesium for the next millennium. South Med J. 1999 Nov;92(11):1040–7.
Print
PDF
Email
View Health Concern
